| (CAD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -66.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HELP.NE returned +84.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +62.5% |
| 1 year | +84.9% |
| 5 years | -86.4% |
| All-time high | $145.92 (Jul 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HELP.NE would be worth today ›No. Cybin D/B/A Helus Pharma has not paid a dividend in the past 12 months.
Cybin D/B/A Helus Pharma is part of the Healthcare sector.
Cybin D/B/A Helus Pharma has a market cap of 1.32B CAD, based on the latest quote.
Cybin D/B/A Helus Pharma is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
